Skip to main content

Department ofPublic Health

H. Westley Clark

H. Westley Clark
Dean's Executive Professor

B.A. in Chemistry, Wayne State University

M.D. University of Michigan School of Medicine

M.P.H. in Medical Care Organization, University of Michigan School of Public Health

Psychiatric Residency, University of Michigan Neuropsychiatric Institute

J.D. Harvard University Law School

Fellowship in Addiction Psychiatry, San Francisco Veterans Affairs Medical Center

Board Certified in Psychiatry, American Board of Psychiatry and Neurology

Subspecialty Certification in Addiction Psychiatry, American Board of Psychiatry and Neurology

Licensed to Practice Medicine:  Michigan, Maryland, Massachusetts and California

DEA registered physician

Licensed to practice law, Washington, DC

Public Health Interests

My current interests focus on clinical and policy issues associated with the use of psychoactive substances. I have a particular interest in privacy and confidentiality,  ethical issues associated with substance use policy, innovations associated with behavioral health prevention and treatment, health information technology and general health policy.  Behavioral Health issues are often ignored but play a major role in people’s lives.  From a public health and public safety perspective, the biological and social determinants of health are essential considerations for society.  During the 2015-2016 academic year, I joined the National Advisory Council of the National Institute on Drug Abuse.


PHSC  160  Substance Abuse and Addiction

PHSC 7  Ethics and Public Health

PHSC    Health Policy


K.Blum, M.Gold, H. W. Clark, K. Dushaj, R.D. Badgaiyan (2016). Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone. Substance Use and Misuse. DOI:10.1080/10826084.2016.1200097.

H. W. Clark (2016) Federal Involvement in Pain Management Policy, book chapter in Treating Comorbid Opioid Use Disorder in Chronic Pain Springer, •ISBN 978-3-319-29863-4

J. Lee, T.F. Kresina, M. Campopiano, R. Lubran, H. W. Clark (2015). Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care. .Biomed Res Int. 2015;2015:137020. doi: 10.1155/2015/137020. Epub 2015 Jan 5. Review. (Open Access)

M.L. Dennis, H.W. Clark, L.N. Huang (2014) The need and opportunity to expand substance use disorder treatment in school-based setting. Advances in School Mental Promotion. 7(2): 75-87.

T. Kresina , R. Lubran ,H.W.  Clark, L. W. Cheever  (2012)  Substance Abuse Treatment, HIV/AIDS, and the Continuum of Response for People Who Inject Drugs.  Adv Prev Med. 2012;2012:541489. doi: 10.1155/2012/541489. Epub 2012 Nov 29. (Open Access)

B. Tai , M. Boyle, U.  Ghitza, R M.  Kaplan, H. W.  Clark,  K.  Gersing. (2012)  Meaningful use of electronic behavioral health data in primary health care. Sci Transl Med. 1;4(119):119mr3. doi: 10.1126/scitranslmed.3003324.

H.W. Clark (2011) A truly integrated treatment system must be both patient- and process-focused. Addiction. 2011 Dec;106(12):2068-9. doi: 10.1111/j.1360-0443.2011.03556.x.

D.L. Whiters , S. Santibanez , D. Dennison D,  H. W. Clark (2010) A case study in collaborating with Atlanta-based African-American churches: a promising means for reaching inner-city substance users with rapid HIV testing. J Evid Based Soc Work.;7(1):103-14. doi: 10.1080/15433710903175981.

L. Kaplan, C.Nugent, M. Baker, H.W. Clark, B.M. Veysey (2010) Introduction: The Recovery Community Service Program. Alcoholism Treatment Quarterly. 28(3): 244-255.

T.F.  Kresina , R.D. Bruce, Lubran R, Clark HW. (2008) Integration of viral hepatitis services into opioid treatment programs. J Opioid Manag..

B.K. Madras , W.M. Compton, D. Avula, T.  Stegbauer,  J.B. Stein, H.W. Clark. (2009) Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend Jan 1;99(1-3):280-95. doi: 10.1016/j.drugalcdep.2008.08.003. Epub 2008 Oct 16. (Open Access)

T.F. Kresina , D. Sylvestre, L. Seeff,  A.H. Litwin , K. Hoffman, R.  Lubran, H.W. Clark. (2008) Hepatitis infection in the treatment of opioid dependence and abuse. Subst Abuse. Apr 28;1:15-61. eCollection 2008 (Open Access)

H. W. Clark, A.K.  Power, C.E.  Le Fauve, E.I. Lopez (2008)  Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders.  J Subst Abuse Treat.Jan;34(1):3-13. Epub 2007 Jun 15.

T.F. Kresina, K.  Hoffman, R. Lubran, H. W. Clark (2007) Integrating hepatitis services into substance abuse treatment programs: new initiatives from SAMHSA. Public Health Rep. 2007;122 Suppl 2:96-8  (Open Access)

H. W. Clark, A.C. Bizzell  (2006) A federal perspective on the abuse of prescription stimulants. Pediatr Ann. 2006 Aug;35(8):594-7.

H. W. Clark, A.K. Power (2005)  Women, Co-occurring Disorders, and Violence Study: a case for trauma-informed care. J Subst Abuse Treat. 2005 Mar;28(2):145-6

H. W. Clark (2003) Office-based practice and opioid-use disorders. N Engl J Med. Sep 4;349(10):928-30

H. W. Clark (2003) New drug buprenorphine can treat patients addicted to heroin or prescription pain medications. W V Med J. Jan-Feb;99(1):42.

H. W. Clark, MacNeill Horton, M. Dennis , T.F. Babor  (2002) Moving from research to practice just in time: the treatment of cannabis use disorders comes of age.  Addiction.  Dec;97 Suppl 1:1-3.

H. W. Clark, B. Johnson (2002) Legal issues facing physicians: substance abuse in the workplace. Occup Med. 2002 Jan-Mar;17(1):119-35,

H. W. Clark (2001) A new era in opioid dependency treatment. Recent law allows qualified physicians to provide care in office setting. Postgrad Med. Jun;109(6):15-6, 25

H. W. Clark, C.L. Masson, K.L. Delucchi, S.M. Hall, K.L. Sees (2001) Violent traumatic events and drug abuse severity. J Subst Abuse Treat. Mar;20(2):121-7

H. W. Clark (2001) Residential substance abuse treatment for pregnant and postpartum women and their children: treatment and policy implications.  Child Welfare. Mar-Apr;80(2):179-98.

K.L. Sees,  K.L. Delucchi, C. Masson, A. Rosen, H.W. Clark, H. Robillard, P. Banys, S.M. Hall. (2000) Methadone maintenance for opioid dependence.  JAMA. Aug 9;284(6):694-5.

V. Sclafani,  H. W. Clark, M. Tolou-Shams, C.W. Bloomer, G.A. Salas, D. Norman,  G. Fein. (1998) Premorbid brain size is a determinant of functional reserve in abstinent crack-cocaine and crack-cocaine-alcohol-dependent adults.  J Int Neuropsychol Soc. Nov;4(6):559-65.

V. Sclafani, D.L. Truran, C. Bloomer, M. Tolou-Shams, H.W. Clark, D. Norman, D. Hannauer, G. Fein. (1998) Abstinent chronic crack-cocaine and crackcocaine/alcohol abusers evidence normal hippocampal volumes on MRI despite persistent cognitive impairments.  Addict Biol.  Jul;3(3):261-70. doi: 10.1080/13556219872074.

R. Weinstock, H. W. Clark (1997) Confidentiality conundrum.  Am J Psychiatry.  Oct;154(10):1483-4

P.M. Reilly, K.L. Sees, M.S. Shopshire, S.M. Hall, K.L. Delucchi, P. Banys, H. W. Clark,N. A. Piotrowshi (1995)  Self-efficacy and illicit opioid use in a 180-day methadone detoxification treatment. J Consult Clin Psychol. Feb;63(1):158-62

N.A. Piotrowski, H. W. Clark, S.M. Hall (1994) Treatment research with crack-cocaine-dependent male veterans: the efficacy of different recruitment strategies. Am J Drug Alcohol Abuse.  Nov;20(4):431-43.

S.M. Hall, S. Tunis, E. Triffleman, P. Banys, H.W. Clark, D. Tusel, P. Stewart, D. Presti  (1994)Continuity of care and desipramine in primary cocaine abusers. J Nerv Ment Dis. Oct;182(10):570-5.

P.M. Reilly, H. W. Clark, M.S. Shopshire, E.W. Lewis, D.J Sorensen (1994) Anger management and temper control: critical components of posttraumatic stress disorder and substance abuse treatment. J Psychoactive Drugs. 1994 Oct-Dec;26(4):401-7.

J.E. Zweben, H.W. Clark, D.E. Smith (1994) Traumatic experiences and substance abuse: mapping the territory.J Psychoactive Drugs.  Oct-Dec;26(4):327-44.

P. Banys, H. W. Clark, D.J. Tusel, K. Sees, P. Stewart, L. Mongan, K. Delucchi, E. Callaway (1994). An open trial of low dose buprenorphine in treating methadone withdrawal. J Subst Abuse Treat.  Jan-Feb;11(1):9-15.

K. L.. Sees, H. W. Clark (1993). Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage. Jul;8(5):257-64.

H. W. Clark, K.L. Sees (1993). Opioids, chronic pain, and the law. J Pain Symptom Manage.Jul;8(5):297-305.

H. W. Clark, J.M. Corbett (1993). Needle exchange programs and social policy.  J Ment Health Adm. Spring;20(1):66-71.

K. L. Sees, H. W. Clark (1993)  When to begin smoking cessation in substance abusers. J Subst Abuse Treat. 1993 Mar-Apr;10(2):189-95.

R.H. Schwartz, H. W. Clark, P.S. Meek  (1993). Laboratory tests for rapid screening of drugs of abuse in the workplace: a review. J Addict Dis. 1993;12(2):43-56

H.W. Clark, K.L. Sees (1992) Drug testing and the toilet bowl blues.JAMA. Nov 4;268(17):237

H. W. Clark (1991) Policy and medical-legal issues in the prescribing of controlled substances. J Psychoactive Drugs. Oct-Dec;23(4):321-8.

D. E. Boatwright, H. W. Clark (1991) Safe use of benzodiazepines and other drugs: the pharmacist's duty to counsel. Am J Hosp Pharm. Jun;48(6):1291-6.

H.W. Clark (1991) The White Labyrinth: Cocaine and Political Power.  Journal of Psychoactive Drugs. 23(3): 293-294.

H. W. Clark (1990) The medical review officer and workplace drug testing. J Psychoactive Drugs. Oct-Dec;22(4):435-45.

H. W. Clark (1990). The role of physicians as medical review officers in workplace drug testing programs. In pursuit of the last nanogram.  West J Med. May;152(5):514-24

J.E. Zweben, H.W. Clark (1990)  Unrecognized substance misuse: clinical hazards and legal vulnerabilities.  Int J Addict.;25(12A):1431-51.

L.J. Nelson, H.W. Clark, R.L. Goldman, J.E. Schore (1989) Taking the train to a world of strangers: health care marketing and ethics. Hastings Cent Rep. Sep-Oct;19(5):36-43.

P.S. Meek, H.W. Clark, V.L. Solana (1989). Neurocognitive impairment: the unrecognized component of dual diagnosis in substance abuse treatment. J Psychoactive Drugs. Apr-Jun;21(2):153-60.

H. W. Clark, J.E. Zweben (1989) Legal vulnerabilities in the treatment of chemically dependent dual diagnosis patients. J Psychoactive Drugs.  Apr-Jun;21(2):251-7.

H. W. Clark, K.L.Sees, J.A. Nathan (1988)  Clinical and legal aspects of nonphysician prescription of vitamins, amino acids and other nutritional supplements. J Psychoactive Drugs. Jul-Sep;20(3):355-74.

K.L.. Sees, H.W. Clark (1988)  Use of clonidine in nicotine withdrawal.  J Psychoactive Drugs. Jul-Sep;20(3):263-8.

R.D. Daigle, H.W. Clark, M.J. Landry (1988)  A primer on neurotransmitters and cocaine. J Psychoactive Drugs. Jul-Sep;20(3):283-95.

H. W. Clark, P. Washburn (1988) Testing for human immunodeficiency virus in substance abuse treatment. J Psychoactive Drugs. Apr-Jun;20(2):203-11.

H. W. Clark (1987)  On professional therapists and Alcoholics Anonymous. J Psychoactive Drugs.  Jul-Sep;19(3):233-42

S.S. Sharfstein, H. W. Clark (1980) Why psychiatry is a low-paid medical specialty. Am J Psychiatry. Jul;137(7):831-3.

F. E. Noe, K. Bhatt, H.W. Clark (1969) Electrical impedance spirometry for monitoring respiration during anesthesia. Anesth Analg. Mar-Apr;48(2):282-91.

In the News

April 14, 2021

H. Westley Clark wrote an opinion piece with David L. Nathan and Joycelyn Elders called "Under fire on race, the AMA should drop its support for the war on drugs" in CNN.

March 17, 2021

Advocates put forth H. Westley Clark as a candidate for the top drug policy official because of his specialized experience fighting substance-use disorders. Also Washington Post 2Politico, and News India Times.

February 4, 2021

Westley Clark wrote the op-ed "The Limitations of Context Neutral Prevention, Treatment and Recovery" about "black patients [who] come to substance use disorder (SUD) treatment with a spectrum of experiences that traditional paradigms of medical intervention often do not address." This op-ed is part of Basis Online's Black History Month Special Series.

    Valeriote Goldman Symposium: Public Health & Social Justice